Skip to main content
Equibles
ATRA logo

ATRA · Atara Biotherapeutics, Inc.

Track ATRA — free

Use ATRA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ATRA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.09 -0.42 (-4.94%) At close · Aug 14
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Accordingly, we have concluded that substantial doubt exists with respect to our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”
View the 10-Q filed Aug 12, 2026
Market Cap
$81.21M
Shares
10.04M

Atara Biotherapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Atara Biotherapeutics, Inc. (ATRA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $7.31M −$88.11M '22 Q1 22-05-05 · $51.58M $18.47M '22 Q2 22-08-08 · $4.46M −$84.09M '22 Q3 22-11-08 LATEST ▼52.1% $2.14M −$69.80M '23 Q3 23-11-01
Earnings call
FY23 · Q3
2023-11-01
Atara Biotherapeutics, Inc. Q3 FY2023 Earnings Call
Revenue
$2.14M
▼ 52.1% YoY
Diluted EPS
$-16.40
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-11-08
Atara Biotherapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$4.46M
Diluted EPS
$-20.50
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Atara Biotherapeutics, Inc. Q2 FY2022 Earnings Call
Revenue
$51.58M
Diluted EPS
$4.50
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Atara Biotherapeutics, Inc. Q1 FY2022 Earnings Call
Revenue
$7.31M
Diluted EPS
$-21.75
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
Atara Biotherapeutics, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Atara Biotherapeutics, Inc. Q3 FY2021 Earnings Call
Diluted EPS
$-22.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Atara Biotherapeutics, Inc. Q2 FY2021 Earnings Call
Diluted EPS
$-22.75
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Atara Biotherapeutics, Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-01
Atara Biotherapeutics, Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Atara Biotherapeutics, Inc. Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Atara Biotherapeutics, Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Atara Biotherapeutics, Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Atara Biotherapeutics, Inc. Q4 FY2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–13 of 13 earnings calls
Key facts CIK 1604464 CUSIP 046513206 13F (30d) 38 filings 36 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)